Aerpio Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aerpio Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 23% to $5,508,000. Profit margin reached -670%. Total operating expenses were $7,437,000.
Profit Margin
| 2011 | 0 | -22.39K | |
|---|---|---|---|
| 2017 | 0 | -15.12M | |
| 2018 | 0 | -16.70M | |
| 2019 | 0 | -19.47M | |
| 2020 | 823K | -22.18M | -2695.14% |
| 2021 | 4.47M | -23.15M | -517.55% |
| 2022 | 5.50M | -36.91M | -670.24% |
ARPO Income Statement (2011 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2011 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 5.50M | 4.47M | 823K | 0 | 0 | 0 | 0 |
Cost of revenue | 35.01M | 20.01M | 14.44M | 8.32M | 0 | 0 | 0 |
Gross profit | -29.50M | -15.54M | -13.62M | -8.32M | 0 | 0 | 0 |
Operating exp. | |||||||
Research and development | 35.01M | 20.01M | 14.44M | 9.82M | 15.13M | 12.74M | 0 |
Selling and marketing | 0 | 0 | 0 | 1.50M | 1.4M | 1.36M | 0 |
Total operating expenses | 7.43M | 7.55M | 7.95M | 10.31M | 15.93M | 15.33M | 20.50K |
Operating income | -36.94M | -23.82M | -21.58M | -17.98M | -10.89M | -15.45M | -20.50K |
Other income (expenses), net | 29K | 667K | -594K | -1.49M | -5.81M | 330K | 1.88K |
Income before tax | -36.91M | -23.15M | -22.18M | -19.47M | -16.70M | -15.12M | -22.39K |
Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income | -36.91M | -23.15M | -22.18M | -19.47M | -16.70M | -15.12M | -22.39K |
Earnings per share | |||||||
Basic EPS | -1.08 | -0.96 | -1.35 | -2.43 | -3.59 | -2.25 | -0.06 |
Diluted EPS | -1.08 | -0.96 | -1.35 | -2.43 | -3.59 | -2.25 | -0.06 |
| Data source |